Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 4/20 | 0.71 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.60 |
| ▸ | HTR3B | O95264 | 1/20 | 0.60 |
| ▸ | HTR3A | P46098 | 1/20 | 0.60 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.60 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.60 |
| ▸ | HTR1A | P08908 | 5/20 | 0.59 |
| ▸ | HTR2A | P28223 | 4/20 | 0.59 |
| ▸ | DRD3 | P35462 | 3/20 | 0.59 |
| ▸ | HTR2C | P28335 | 2/20 | 0.53 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6526782 | 0.99 | KCNH2 (0.70) | KCNH2HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL3153996 | 0.90 | HTR3E (0.66) | KCNH2HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL4519830 | 0.83 | KCNH2 (1.00) | KCNH2HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL14761536 | 0.83 | KCNH2 (0.50) | KCNH2HTR3AHTR1AHTR2ADRD3 | |
| SCHEMBL6525544 | 0.82 | KCNH2 (0.63) | KCNH2HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL4521524 | 0.80 | KCNH2 (1.00) | KCNH2HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL25695217 | 0.79 | HTR3E (0.67) | KCNH2HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL14761822 | 0.78 | CYP2D6 (0.53) | KCNH2HTR3AHTR1AHTR2ADRD3 | |
| SCHEMBL13711981 | 0.78 | KCNH2 (0.87) | KCNH2HTR3EHTR3BHTR3AHTR3D | |
| SCHEMBL14761434 | 0.78 | HTR1A (0.49) | KCNH2HTR1AHTR2ADRD3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110059019-A1 | NOVEL ARYL PIPERAZINE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE AND SEROTONIN RECEPTORS | NEUROSEARCH A/S (DK) | 2011-03-10 | — | — | US | claimed |
| US-20110059019-A1 | NOVEL ARYL PIPERAZINE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE AND SEROTONIN RECEPTORS | NEUROSEARCH A/S (DK) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059019-A1 | NOVEL ARYL PIPERAZINE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE AND SEROTONIN RECEPTORS | HTR3A, HTR2A, HTR5A | KCNH2 828/4885HTR3E 10/4885HTR3B 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.